Immunovia AB's market cap is currently $16.14M. The company's EPS TTM is $-0.008508162; its P/E ratio is -0.56; Immunovia AB is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
